The Pretreatment Plasma Prognosis Biomarkers for Advanced NSCLC Patients Treated by Bevacizumab Plus Chemotherapy and the Correlation Between Them

Jingru Liu(Shandong University), Jie Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Min Wu(Zhongda Hospital Southeast University), Xue Meng(Shandong First Medical University), Zhenhua Gao(Shandong University), Shasha Wang(Chinese PLA General Hospital), Jianing Li(Merck & Co., Inc., Rahway, NJ, USA (United States))
Research Square
August 6, 2021
10.21203/rs.3.rs-776778/v1
Cited by 0

Related Papers

Synthesis of Hemoglobin Conjugated Polymeric Micelle: A ZnPc Carrier with Oxygen Self-Compensating Ability for Photodynamic Therapy
|Biomacromolecules|2015|136
Endometrial preparation for frozen–thawed embryo transfer cycles: a systematic review and network meta-analysis
|Journal of Assisted Reproduction and Genetics|2021|109
Decellularized Swine Dental Pulp as a Bioscaffold for Pulp Regeneration
|BioMed Research International|2017|80
Artificial intelligence-based screening for diabetic retinopathy at community hospital
|Eye|2019|78
Computed Tomography-Based Delta-Radiomics Analysis for Discriminating Radiation Pneumonitis in Patients With Esophageal Cancer After Radiation Therapy
|International Journal of Radiation Oncology*Biology*Physics|2021|72